Effects of glucagon‐like peptide‐1 receptor agonists on glycated haemoglobin and continuous glucose monitoring metrics as adjunctive therapy to insulin in adults with type 1 diabetes: A meta‐analysis of randomized controlled trials
Effekte von Glucagon-like-Peptid-1-Rezeptoragonisten auf glykiertes Hämoglobin und CGM-Messwerte als Zusatztherapie zu Insulin bei Erwachsenen mit Typ-1-Diabetes: eine Metaanalyse randomisierter kontrollierter Studien
Diabetes, Obesity and Metabolism · 2024-12 · 26 (12) · 6043-6054
DOI: 10.1111/dom.15979 ↗Auf einen Blick
Sechs RCTs mit 378 Erwachsenen mit Typ-1-Diabetes: GLP-1RA zusätzlich zu Insulin senkten HbA1c leicht, veränderten die TIR aber nicht. Die Zeit unterhalb des Zielbereichs war länger.
Fragestellung
Welche Wirkung haben GLP-1-Rezeptoragonisten als Zusatz zu Insulin auf HbA1c und CGM-Messwerte bei Erwachsenen mit Typ-1-Diabetes?
Methode
Systematische Literaturrecherche in Medline, Cochrane Library und Google Scholar bis 27. Mai 2024; Metaanalyse randomisierter kontrollierter Studien mit Random-effects-Modell.
Ergebnisse
6 RCTs mit 378 Personen. HbA1c: MD −0,21 % (95 %-KI −0,36 bis −0,06; p = 0,007). TIR: MD −0,22 % (95 %-KI −2,39 bis 1,95; p = 0,84). Time below range: MD 1,13 % (95 %-KI 0,50 bis 1,76; p < 0,001).
Schlussfolgerung der Autor:innen
Die Autor:innen folgern, dass eine Add-on-Therapie mit GLP-1RAs bei Typ-1-Diabetes keine signifikanten Vorteile für CGM-Messwerte bringt und mit einer längeren Zeit unterhalb des Zielbereichs verbunden ist.
Kernaussagen
- HbA1c sank unter GLP-1RA um MD −0,21 %
- TIR blieb gegenüber Placebo ähnlich
- Time below range war unter GLP-1RA höher
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Metaanalyse in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 30.09.2024. Verfasst von Paschalis Karakasis und 8 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Cardiology, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki, Greece. Hauptthemen laut MEDLINE: Glycated Hemoglobin, Randomized Controlled Trials as Topic, Diabetes Mellitus, Type 1, Hypoglycemic Agents. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
To conduct a meta‐analysis of randomized controlled trials (RCTs) to evaluate the effect of glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) on glycated haemoglobin (HbA1c) and continuous glucose monitoring (CGM) metrics as an adjunct to insulin therapy in adults with type 1 diabetes mellitus (T1D).
Methods
A systematic literature search was conducted through Medline (via PubMed), Cochrane Library, and Google Scholar up to 27 May 2024. Dual‐independent study selection, data extraction, and quality assessment were performed. Results were summarized using random‐effects meta‐analysis.
Results
Six RCTs were identified, involving a total of 378 individuals with T1D. The use of GLP‐1RAs in addition to standard insulin therapy was associated with a significant reduction in HbA1c (mean difference [MD] −0.21%, 95% confidence interval [CI] −0.36 to −0.06; p = 0.007) and a similar time in range (TIR) compared to placebo (MD −0.22%, 95% CI −2.39 to 1.95; p = 0.84). GLP‐1RA therapy resulted in a significantly higher time below range (MD 1.13%, 95% CI 0.50 to 1.76; p < 0.001) and a lower time above range compared with placebo (MD −1.83%, 95% CI −2.51 to −1.15; p < 0.001). Nonsignificant differences were noted for the secondary outcomes, including the mean amplitude of glucose excursion, continuous overall net glycaemic action for 60 min, mean daily glucose, coefficient of variation, and mean standard deviation of weekly glucose levels.
Conclusion
Our findings suggest that, in individuals with T1D, add‐on therapy with GLP‐1RAs does not confer significant benefits in terms of CGM metrics and is associated with a longer time below the target glycaemic range.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Second Department of Cardiology, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki, Greece.
- Second Propaedeutic Department of Internal Medicine, Hippokration General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
- Department of Internal Medicine, Faculty of Medicine, University of Ioannina, Ioannina, Greece.
- Primary Health Care Center, Faculty of Medicine, University of Montenegro, Podgorica, Montenegro.
- Clinic for Endocrinology, Diabetes and Metabolic Disorders, Clinical Centre of Vojvodina, Medical Faculty, University of Novi Sad, Novi Sad, Serbia.
- Diabetes Centre, Second Department of Internal Medicine, Democritus University of Thrace, University Hospital of Alexandroupolis, Alexandroupolis, Greece.
ORCID-Profile: Paschalis Karakasis, Dimitrios Patoulias, Djordje S Popovic
Zitieren
APA
Karakasis, P., Koufakis, T., Patoulias, D., Barkas, F., Klisic, A., Mitrovic, M., Doumas, M., Papanas, N., & Popovic, D. S. (2024). Effects of glucagon‐like peptide‐1 receptor agonists on glycated haemoglobin and continuous glucose monitoring metrics as adjunctive therapy to insulin in adults with type 1 diabetes: A meta‐analysis of randomized controlled trials. Diabetes, Obesity and Metabolism, 26(12), 6043-6054. https://doi.org/10.1111/dom.15979
Vancouver
Karakasis P, Koufakis T, Patoulias D, Barkas F, Klisic A, Mitrovic M, et al. Effects of glucagon‐like peptide‐1 receptor agonists on glycated haemoglobin and continuous glucose monitoring metrics as adjunctive therapy to insulin in adults with type 1 diabetes: A meta‐analysis of randomized controlled trials. Diabetes, Obesity and Metabolism. 2024;26(12):6043-6054. doi:10.1111/dom.15979
BibTeX
@article{Karakasis2024,
author = {Karakasis, Paschalis and Koufakis, Theocharis and Patoulias, Dimitrios and Barkas, Fotios and Klisic, Aleksandra and Mitrovic, Milena and Doumas, Michael and Papanas, Nikolaos and Popovic, Djordje S},
title = {Effects of glucagon‐like peptide‐1 receptor agonists on glycated haemoglobin and continuous glucose monitoring metrics as adjunctive therapy to insulin in adults with type 1 diabetes: A meta‐analysis of randomized controlled trials},
journal = {Diabetes, Obesity and Metabolism},
year = {2024},
volume = {26},
number = {12},
pages = {6043--6054},
doi = {10.1111/dom.15979}
}
EUVIMED